August 30, 2019
Charles B. Simone, II, MD, a nationally-recognized expert in proton therapy at the University of Pennsylvania, has been named the new Medical Director of the MPTC. Dr. Simone will also be appointed Associate Professor in the UM SOM Department of Radiation Oncology and will begin in his new position in November 2016.
“Dr. Simone brings a wealth of knowledge and experience to this highly important role,” said Dean Reece, who is also the vice president for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor. “He will be an essential asset to the MPTC as it continues to grow and develop into one of the premier treatment and research centers in the world.”
As Medical Director, Dr. Simone will continue to define and implement processes ensuring that MPTC is integrated with the Radiation Oncology Department and The University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center, the University of Maryland Medical Center/System, and the UM SOM.
He will also participate in development of clinical trials and research protocols, assume a leadership role within the Maryland Proton Alliance, a partnership between UM SOM and MPTC, and provide expertise in refining criteria for proton therapy patient selection within the department’s clinical practice guidelines.
“I have known Dr. Simone for years, and he is both an excellent researcher and a superb clinician,” said Dr. Regine. “At MPTC, we are excited that he will make substantial contributions to our enterprise.”
Prior to coming to MPTC, Dr. Simone was co-director of the Penn Mesothelioma and Pleural Program at the University of Pennsylvania Health System. He was also Associate Professor in the Department of Radiation Oncology at the University of Pennsylvania School of Medicine and the Thoracic Oncology Service Chief for the University of Pennsylvania Health System.
He is nationally recognized as an expert for the use of proton therapy in the treatment of thoracic malignancies, development of clinical trial strategies, and innovative research in thoracic radiation oncology. He chairs the Lung Committee of the Proton Collaborative Group, a national cooperative research coalition, is a member of the American Society for Radiation Oncology Lung Resource Panel, and a member of the NRG Oncology Lung Cancer Committee and the NRG Oncology Radiation Oncology Committee.
“I am very excited to work at this cutting-edge center,” said Dr. Simone. “Our goal will be to foster world-class treatment for cancers using proton therapy, as well as to further research in this area and educate outstanding researchers and clinicians.”
Dr. Simone received an MD degree from University of Pennsylvania School of Medicine. He completed an internship at the Graduate Hospital in Philadelphia, and a residency at the Radiation Oncology Branch of the National Cancer Institute, where he served as the Chief Resident. In his research, Dr. Simone has worked extensively on radiation therapy for thoracic tumors. He has coauthored more than 150 peer-reviewed manuscripts, chapters, reviews, and editorials, and has presented more than 100 scientific lectures to national and international audiences.